We are BrainScope

BrainScope is a medical neuro-technology company that is pioneering the assessment of brain injury, including concussion. The company’s innovative BrainScope One system
(FDA-cleared as Ahead 300[1]) is an easy-to-use, non-invasive, hand-held platform that empowers physicians to make more accurate head injury assessments
quickly at the point-of-care.

Our Company »


[1] Subsequent labelling modification that clarified device capabilities with regard to “concussion/mTBI” in the Indications for Use was cleared on May 18, 2018 (K181179).



BrainScope has received the
Frost & Sullivan
2017 Best Practices Award
Traumatic Brain Injury Assessment
New Product Innovation 

Click here to view report 

Prix Galien.jpg

BrainScope has been
nominated for the
2017 Prix Galien USA Award
for Best Medical Technology Product

Click here for press release